Fairvalue-Calculator Fairvalue-Calculator
EN DE

Shanghai Haohai Biological Technology Co (688366) Fair Value & Analysis

Healthcare · CN · Market cap 7.1B CNY

Price¥30.50
Fair Value¥29.03
Upside-4.8%
Quality91/100
Evidence: High Range ¥21.77 – ¥36.29

Fair value as of: Jun 24, 2026

Analysis

Shanghai Haohai Biological Technology Co (688366) currently trades at ¥30.50, while our model-based Fair Value estimate is ¥29.03 — implying the stock looks roughly 4.8% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequency, and ultrasonic instruments. It also engages in the research and development of biological engineering and pharmaceutical products and related technology transfer activities, consulting, and other services; research, development, production, and sales of radio frequency instruments; cell technology and biochemical product technology research and development; computer, communication, and other electronic equipment manufacturing; instrument…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Shanghai Haohai Biological Technology Co (688366) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥29.03 versus a price of ¥30.50 — about −5% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 688366?
Our 21-model fair value for Shanghai Haohai Biological Technology Co is ¥29.03 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥30.50.
What is the quality score of 688366?
Shanghai Haohai Biological Technology Co has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.